Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells

We studied the effects of ANG II on extracellular signal-regulated kinase (ERK)1/2 phosphorylation in rat pituitary cells. ANG II increased ERK phosphorylation in a time- and concentration-dependent way. Maximum effect was obtained at 5 min at a concentration of 10-100 nM. The effect of 100 nM ANG I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Suárez, C.
Otros Autores: Díaz-Torga, G., Gonzalez-Iglesias, A., Vela, J., Mladovan, A., Baldi, A., Becu-Villalobos, D.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2003
Materias:
Acceso en línea:Registro en Scopus
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 17642caa a22016217a 4500
001 PAPER-21461
003 AR-BaUEN
005 20230518205255.0
008 190411s2003 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0042466241 
024 7 |2 cas  |a 1 [[6 (3 methoxyestra 1,3,5(10) trien 17beta yl)amino]hexyl] 1h pyrrole 2,5 dione, 112648-68-7; 2 (2 amino 3 methoxyphenyl)chromone, 167869-21-8; 3,4,5 trimethoxybenzoic acid 8 (diethylamino)octyl ester, 57818-92-5; 4 (3 chloroanilino) 6,7 dimethoxyquinazoline, 153436-53-4; angiotensin, 1407-47-2; egtazic acid, 67-42-5; ethylene glycol 1,2 bis(2 aminophenyl) ether n,n,n',n' tetraacetic acid, 73630-08-7; herbimycin, 77699-47-9; losartan potassium, 124750-99-8; mitogen activated protein kinase 1, 137632-08-7; mitogen activated protein kinase, 142243-02-5; pertussis toxin, 70323-44-3; Angiotensin II, 11128-99-7; Calcium, 7440-70-2; Estrogens; Mitogen-Activated Protein Kinases, EC 2.7.1.37; Phospholipase C, EC 3.1.4.3; Protein Kinase C, EC 2.7.1.37; Receptor, Angiotensin, Type 1; Receptor, Epidermal Growth Factor, EC 2.7.1.112; Receptors, Angiotensin; src-Family Kinases, EC 2.7.1.112; Vasoconstrictor Agents 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a AJPMD 
100 1 |a Suárez, C. 
245 1 0 |a Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells 
260 |c 2003 
270 1 0 |m Becu-Villalobos, D.; Inst. de Biol. Med. Exp.-CONICET, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina; email: dbecu@dna.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Arai, H., Escobedo, J.A., Angiotensin II type 1 receptor signals through raf-1 by a protein kinase C-dependent, ras-independent mechanism (1996) Mol Pharmacol, 50, pp. 522-528 
504 |a Chao, T.S., Byron, K.L., Lee, K.M., Villereal, M., Rosner, M.R., Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor (1992) J Biol Chem, 267, pp. 19876-19883 
504 |a Chen, F.M., Printz, M.P., Chronic estrogen treatment reduces angiotensin II receptors in the anterior pituitary (1983) Endocrinology, 113, pp. 1503-1510 
504 |a De Moel, M.P., Van de Put, F.H., Vermegen, T.M., De Pont, J.H., Willems, P.H., Effect of the aminosteroid, U73122, on Ca2+ uptake and release properties of rat liver microsomes (1995) Eur J Biochem, 234, pp. 626-631 
504 |a Deschepper, C.F., The renin-angiotensin system in the pituitary gland (1991) Trends Endocrinol Metab, 2, pp. 104-107 
504 |a Deschepper, C.F., Seidler, C.D., Steele, M.K., Ganong, W.F., Further studies on the localization of angiotensin II-like immunoreactivity in the anterior pituitary gland of the male rat, comparing various antisera to pituitary hormones and their specificity (1985) Neuroendocrinology, 40, pp. 471-475 
504 |a Diaz-Torga, G.S., Gonzalez Iglesias, A., Achaval-Zaia, R., Libertun, C., Becu-Villalobos, D., Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary Cells (1998) Am J Physiol Endocrinol Metab, 274, pp. E534-E540 
504 |a Eguchi, S., Iwasaki, H., Inagami, T., Numaguchi, K., Yamakawa, T., Motley, E.D., Owada, K.M., Hirata, Y., Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells (1999) Hypertension, 33, pp. 201-206 
504 |a Eguchi, S., Matsumoto, T., Motley, E.D., Utsunomiya, H., Inagami, T., Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells (1996) J Biol Chem, 271, pp. 14169-14175 
504 |a Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E.D., Inagami, T., Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells (1998) J Biol Chem, 273, pp. 8890-8896 
504 |a Enjalbert, A., Sladeczek, F., Guillon, G., Bertrand, P., Shu, C., Epelbaum, J., Garcia-Sainz, A., Bockaert J. II, Angiotensin dopamine modulate both cyclic AMP and inositol phosphate productions in anterior pituitary cells (1986) J Biol Chem, 261, pp. 4071-4075 
504 |a Gonzalez Iglesias, A., Diaz-Torga, G., Lux-Lantos, V., Libertun, C., Becu-Villalobos, D., Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cels (1999) Am J Physiol Endocrinol Metab, 277, pp. E455-E463 
504 |a Gonzalez Iglesias, A., Diaz-Torga, G., Piroli, G., Achaval-Zaia, R., De Nicola, A.F., Libertun, C., Becu-Villalobos, D., Bromocriptine restores angiotensin II response in pituitary hyperplasia (2000) Mol Cell Endocrinol, 165, pp. 67-74 
504 |a Gonzalez Iglesias, A., Suarez, C., Feierstein, C., Diaz-Torga, G., Becu-Villalobos, D., Desensitization of angiotensin II: Effect on [Ca2+] i, inositol triphosphate, and prolactin in pituitary cells (2001) Am J Physiol Endocrinol Metab, 280, pp. E462-E470 
504 |a Herbert, J.M., Augereau, J.M., Gleye, J., Maffran, X., Chelerythrine is a potent and specific inhibitor of protein kinase C (1990) Biochem Biophys Res Commun, 172, pp. 993-999 
504 |a Huang, X.C., Richards, E.M., Sumners, C., Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors (1996) J Biol Chem, 271, pp. 15635-15641 
504 |a Ishida, M., Ishida, T., Thomas, S., Berk, B.C., Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells (1998) Circ Res, 82, pp. 7-12 
504 |a Kakar, S.S., Sellers, J.C., Devor, D.C., Musgrove, L.C., Neill, J.D., Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulation (1992) Biochem Biophys Res Commun, 183, pp. 1090-1096 
504 |a Kunert-Radek, J., Pawlikowski, M., Angiotensin II stimulation of the rat pituitary tumoral cell proliferation in vitro (1992) Biochem Biophys Res Commun, 183, pp. 27-30 
504 |a Leduc, I., Haddad, P., Giasson, E., Meloche, S., Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells (1995) Mol Pharmacol, 48, pp. 582-592 
504 |a Lenkei, Z., Nuyt, A.M., Grouselle, D., Corvol, P., Llorens-Cortes, C., Identification of endocrine cell population expressing the AT 1B subtype of angiotensin II receptors in anterior pituitary (1999) Endocrinology, 140, pp. 472-477 
504 |a Luttrell, L.M., Daaka, Y., Lefkowitz, R.J., Regulation of tyrosine kinase cascades by G-protein-coupled receptors (1999) Curr Opin Cell Biol, 11, pp. 177-183 
504 |a McCormick, F., Signal transduction. How receptors turn Ras on (1993) Nature, 363, pp. 15-16 
504 |a Mogami, H., Lloyd Mills, C., Gallacher, D.V., Phospholipase C inhibitor, U73122, releases intracellular Ca2+, potentiates Ins(1,4,5)P3-mediated Ca2+ release and directly activates ion channels in mouse pancreatic acinar cells (1997) Biochem J, 324, pp. 645-651 
504 |a Molloy, C.J., Taylor, D.S., Weber, H., Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells (1993) J Biol Chem, 268, pp. 7338-7345 
504 |a Murasawa, S., Mori, Y., Nozawa, Y., Gotoh, N., Shibuya, M., Masaki, H., Maruyama, K., Matsubara, H., Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor (1998) Circ Res, 82, pp. 1338-1348 
504 |a Murasawa, S., Mori, Y., Nozawa, Y., Masaki, H., Maruyama, K., Tsutsumi, Y., Shibasaki, Y., Matsubara, H., Role of calcium-sensitive tyrosine kinase Pyk2/CAKβ/RAFTK in angiotensin II-induced Ras/ERK signaling (1998) Hypertension, 32, pp. 668-675 
504 |a Naftilan, A.J., Pratt, R.E., Eldrige, C.S., Lin, H.L., Dzau, V.J., Angiotensin II induces c-fos expression in smooth muscle cells via transcriptional control (1989) Hypertension, 13, pp. 706-711 
504 |a Ohnishi, J., Ishido, M., Shibata, T., Inagami, T., Murakami, K., Miyazaki, H., The rat angiotensin II AT 1A receptor couples with three different signal transduction pathways (1992) Biochem Biophys Res Commun, 186, pp. 1094-1101 
504 |a Pawlikowski, M., Grochal, M., Kulig, A., Zielinski, K., Stepien, H., Kunert-Radek, J., Mucha, S., The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: A quantitative evaluation (1996) Histol Histopathol, 11, pp. 909-913 
504 |a Sadoshima, J., Qiu, Z., Morgan, J.P., Izumo S. II, Angiotensin other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac mycocytes. The critical role of Ca2+-dependent signaling (1995) Circ Res, 76, pp. 1-15 
504 |a Saito, Y., Bradford, B.C., Transactivation: A novel signaling pathway from angiotensin II to tyrosine kinase receptors (2001) J Mol Cell Cardiol, 33, pp. 3-7 
504 |a Sanvitto, G.L., Johren, O., Hauser, W., Saavedra, J.M., Water deprivation upregulates ANG II AT 1 binding and mRNA in rat subfornical organ and anterior pituitary (1997) Am J Physiol Endocrinol Metab, 273, pp. E156-E163 
504 |a Seltzer, A., Pinto, J.E.B., Viglione, P.N., Correa, F.M.A., Libertun, C., Tsutsumi, K., Steele, M.K., Saavedra, J.M., Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary (1992) Neuroendocrinology, 55, pp. 460-467 
504 |a Shah, B.H., Catt, K.J., Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: Roles of protein kinase Cδ, Src/proline-rich tyrosine kinase 2, and epidermal growth factor receptor transactivation (2002) Mol Pharmacol, 61, pp. 343-351 
504 |a Shelat, S.G., King, J.L., Flanagan-Cato, L.M., Fluharty, S.J., Mineralocorticoids and glucocorticoids cooperatively increase salt intake and angiotensin II receptor binding in rat brain (1999) Neuroendocrinology, 69, pp. 339-351 
504 |a Suarez, C., Garcia Tornadú, I., Cristina, C., Vela, J., Gonzalez Iglesias, A., Libertun, C., Diaz-Torga, G., Becu-Villalobos, D., Angiotensin and calcium signaling in the pituitary and hypothalamus (2002) Cell Mol Neurobiol, 22, pp. 315-333 
504 |a Summers, C., Tang, W., Zelezna, B., Raizada, M.K., Angiotensin II receptor subtypes are coupled with distinct signal transduction mechanisms in neurons and astrocytes from rat brain (1991) Proc Natl Acad Sci USA, 88, pp. 7567-7571 
504 |a Takahashi, T., Kawahara, Y., Okuda, M., Ueno, H., Takeshita, A., Yokoyama, M., Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells (1997) J Biol Chem, 272, pp. 16018-16022 
504 |a Takeda-Matsubara, Y., Nakagami, H., Iwai, M., Cui, T.X., Shiuchi, T., Akishita, M., Nahmias, C., Ito, M., Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II (2002) Hypertension, 39, pp. 41-45 
504 |a Terada, Y., Tomita, K., Homma, M.K., Nonoguchi, H., Yang, T., Yamada, T., Yuasa, Y., Marumo, F., Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells (1995) Kidney Int, 48, pp. 1801-1809 
504 |a Tian, Y., Smith, R.D., Balla, T., Catt, K.J., Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells (1998) Endocrinology, 139, pp. 1801-1809 
504 |a Van Biesen, T., Luttrell, L.M., Hawes, B.E., Lefkowitz, R.J., Mitogenic signaling via G protein-coupled receptors (1996) Endocr Rev, 17, pp. 698-714 
504 |a Wen, Y., Nadler, J.L., Gonzales, N., Scott, S., Clauser, E., Natarajan, R., Mechanism of ANG II-induced mitogenic responses: Role of 12-lipoxygenase and biphasic MAP kinase (1996) Am J Physiol Cell Physiol, 271, pp. C1212-C1220 
504 |a Yang, H., Luc, D., Vinson, G.P., Raizada, M.K., Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors (1997) J Neurosci, 17, pp. 1660-1669 
504 |a Zou, Y., Komuro, I., Yamazaki, T., Aikawa, R., Kudoh, S., Shiojima, I., Hiroi, Y., Yazaki, Y., Protein kinase C, but not tyrosihe kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes (1996) J Biol Chem, 271, pp. 33592-33597 
520 3 |a We studied the effects of ANG II on extracellular signal-regulated kinase (ERK)1/2 phosphorylation in rat pituitary cells. ANG II increased ERK phosphorylation in a time- and concentration-dependent way. Maximum effect was obtained at 5 min at a concentration of 10-100 nM. The effect of 100 nM ANG II was blocked by the AT1 antagonist DUP-753, by the phospholipase C (PLC) inhibitor U-73122, and by the MAPK kinase (MEK) antagonist PD-98059. The ANG II-induced increase in phosphorylated (p)ERK was insensitive to pertussis toxin blockade and PKC depletion or inhibition. The effect was also abrogated by chelating intracellular calcium with BAPTA-AM or TMB-8 by depleting intracellular calcium stores with a 30-min pretreatment with EGTA and by pretreatment with herbimycin A and PP1, two c-Src tyrosine kinase inhibitors. It was attenuated by AG-1478, an inhibitor of epidermal growth factor receptor (EGFR) activation. Therefore, in the rat pituitary, the increase of pERK is a Gq- and PLC-dependent process, which involves an increase in intracellular calcium and activation of a c-Src tyrosine kinase, transactivation of the EGFR, and the activation of MEK. Finally, the response of ERK activation by ANG II is altered in hyperplastic pituitary cells, in which calcium mobilization evoked by ANG II is also modified.  |l eng 
593 |a Inst. de Biol. Med. Exp.-CONICET, 1428 Buenos Aires, Argentina 
593 |a Inst. de Biol. Med. Exp.-CONICET, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina 
690 1 0 |a CALCIUM 
690 1 0 |a EPIDERMAL GROWTH FACTOR RECEPTOR 
690 1 0 |a ESTROGEN 
690 1 0 |a MITOGEN-ACTIVATED PROTEIN KINASE 
690 1 0 |a PHOSPHOLIPASE C 
690 1 0 |a PROTEIN KINASE C 
690 1 0 |a 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE 
690 1 0 |a 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE 
690 1 0 |a 3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER 
690 1 0 |a 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE 
690 1 0 |a ANGIOTENSIN 
690 1 0 |a EGTAZIC ACID 
690 1 0 |a EPIDERMAL GROWTH FACTOR RECEPTOR 
690 1 0 |a ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID 
690 1 0 |a HERBIMYCIN 
690 1 0 |a LOSARTAN POTASSIUM 
690 1 0 |a MITOGEN ACTIVATED PROTEIN KINASE 
690 1 0 |a MITOGEN ACTIVATED PROTEIN KINASE 1 
690 1 0 |a PERTUSSIS TOXIN 
690 1 0 |a PROTEIN TYROSINE KINASE INHIBITOR 
690 1 0 |a ADENOHYPOPHYSIS 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ARTICLE 
690 1 0 |a CALCIUM CELL LEVEL 
690 1 0 |a CALCIUM MOBILIZATION 
690 1 0 |a CONCENTRATION RESPONSE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVATION 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a ENZYME INHIBITION 
690 1 0 |a ENZYME PHOSPHORYLATION 
690 1 0 |a FEMALE 
690 1 0 |a HYPOPHYSIS CELL 
690 1 0 |a NONHUMAN 
690 1 0 |a PHOSPHORYLATION 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a RAT 
690 1 0 |a ANGIOTENSIN II 
690 1 0 |a ANIMALS 
690 1 0 |a CALCIUM 
690 1 0 |a CELLS, CULTURED 
690 1 0 |a ESTROGENS 
690 1 0 |a FEMALE 
690 1 0 |a MITOGEN-ACTIVATED PROTEIN KINASES 
690 1 0 |a PHOSPHOLIPASE C 
690 1 0 |a PHOSPHORYLATION 
690 1 0 |a PITUITARY GLAND, ANTERIOR 
690 1 0 |a PROTEIN KINASE C 
690 1 0 |a RATS 
690 1 0 |a RATS, SPRAGUE-DAWLEY 
690 1 0 |a RECEPTOR, ANGIOTENSIN, TYPE 1 
690 1 0 |a RECEPTOR, EPIDERMAL GROWTH FACTOR 
690 1 0 |a RECEPTORS, ANGIOTENSIN 
690 1 0 |a SRC-FAMILY KINASES 
690 1 0 |a VASOCONSTRICTOR AGENTS 
651 4 |a CELL HYPERPLASIA 
651 4 |a HYPERPLASIA 
653 0 0 |a ag 1478, Biomol, United States; dup 753, DuPont Merck, United States; pd 98059; u 73122 
700 1 |a Díaz-Torga, G. 
700 1 |a Gonzalez-Iglesias, A. 
700 1 |a Vela, J. 
700 1 |a Mladovan, A. 
700 1 |a Baldi, A. 
700 1 |a Becu-Villalobos, D. 
773 0 |d 2003  |g v. 285  |h pp. E645-E653  |k n. 3 48-3  |p Am. J. Physiol. Endocrinol. Metab.  |x 01931849  |t American Journal of Physiology - Endocrinology and Metabolism 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042466241&partnerID=40&md5=898a46379d4f070580d3b21ee4611961  |y Registro en Scopus 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_01931849_v285_n348-3_pE645_Suarez  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01931849_v285_n348-3_pE645_Suarez  |y Registro en la Biblioteca Digital 
961 |a paper_01931849_v285_n348-3_pE645_Suarez  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion